Parexel International (MA) Corp Sustainability Reports

Parexel International (MA) Corporation operates as a global contract research organization (CRO) providing comprehensive clinical development and biopharmaceutical services. The company manages clinical trials spanning Phases I through IV, offering clinical logistics, regulatory consulting, and drug safety assessments to streamline medical therapy commercialization.

Sector: Professional & technical services

Country: United States

Exchange: Nasdaq

LEI: 549300GCZVUYB6P2OA17

3 reports from 2021 to 2025

• Parexel International (MA) Corp 2025 Sustainability and Impact Report
• Parexel International (MA) Corp 2024 Environmental, Social and Governance (ESG) Report
• Parexel International (MA) Corp 2021 Our Environmental, Social and Governance (ESG) Approach